Aristospan Injection 20
- Generic Name: triamcinolone hexacetonide injectable suspension
- Brand Name: Aristospan Injection 20 mg
Aristospan Injection 20 mg(Triamcinolone Hexacetonide Injectable Suspension) side effects drug center
Aristospan Injection 20 Side Effects Center
Aristospan (triamcinolone hexacetonide) Injectable Suspension is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Aristospan is usually given in these conditions only as a short-term treatment of a severe or aggravated episode. Aristospan is also injected into soft tissues of the body to treat certain skin disorders caused by autoimmune conditions such as lupus, psoriasis, lichen planus, and others. Common side effects of Aristospan include:
- nausea
- bloating
- appetite changes
- stomach or side pain
- headache
- sleep problems (insomnia)
- acne
- scaling
- other skin changes
- a wound that is slow to heal
- thinning hair
- bruising or swelling
- sweating more than usual, or
- irregular menstrual periods
The initial dosage of Aristospan may vary from 2 to 48 mg per day and is individualized based on the disease being treated and the response of the patient. Aristospan may interact with birth control pills or hormone replacement therapy, blood thinners, cyclosporine, digoxin, insulin or oral diabetes medications, isoniazid, rifampin, seizure medications, antibiotics, aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant while using Aristospan. Aristospan can pass into breast milk and may harm a nursing baby. Do not breastfeed while using Aristospan.
Our Aristospan (triamcinolone hexacetonide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Aristospan Injection 20 Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
- (after injection into a joint space) increased pain or swelling, joint stiffness, fever, and general ill feeling;
- blurred vision, tunnel vision, eye pain, or seeing halos around lights;
- unusual changes in mood or behavior;
- swelling, rapid weight gain, feeling short of breath;
- stomach cramps, vomiting, diarrhea, bloody or tarry stools, rectal irritation;
- sudden numbness or weakness (especially on one side of the body);
- a seizure (convulsions);
- severe headache, blurred vision, pounding in your neck or ears;
- increased pressure inside the skull--severe headaches, ringing in your ears, dizziness, nausea, vision problems, pain behind your eyes; or
- signs of low adrenal gland hormones--flu-like symptoms, headache, depression, weakness, tiredness, diarrhea, vomiting, stomach pain, craving salty foods, and feeling light-headed.
Certain side effects may be more likely with long-term use or repeated doses of triamcinolone injection.
Steroids can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine.
Common side effects may include:
- skin changes (acne, dryness, redness, bruising, discoloration);
- increased hair growth, or thinning hair;
- nausea, bloating, appetite changes;
- stomach or side pain;
- cough, runny or stuffy nose;
- headache, sleep problems (insomnia);
- a wound that is slow to heal;
- sweating more than usual; or
- changes in your menstrual periods.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Aristospan Injection 20 (Triamcinolone Hexacetonide Injectable Suspension)
Aristospan Injection 20 Professional Information
SIDE EFFECTS
(listed alphabetically, under each subsection)
Allergic Reactions
Anaphylactoid reactions, anaphylaxis, angioedema.
Cardiovascular
Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Dermatologic
Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymoses and petechiae, edema, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.
Endocrine
Decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetics, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness, (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients.
Fluid and Electrolyte Disturbances
Congestive heart failure in susceptible patients, fluid retention, hypokalemic alkalosis, potassium loss, sodium retention.
Gastrointestinal
Abdominal distention, bowel/bladder dysfunction (after intrathecal administration), elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis.
Metabolic
Negative nitrogen balance due to protein catabolism.
Musculoskeletal
Aseptic necrosis of femoral and humeral heads, calcinosis (following intra-articular or intralesional use), Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, postinjection flare (following intra-articular use), steroid myopathy, tendon rupture, vertebral compression fractures.
Neurologic/Psychiatric
Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychic disorders, vertigo. Arachnoiditis, meningitis, paraparesis/paraplegia, and sensory disturbances have occurred after intrathecal administration (see WARNINGS: Infections: Neurologic).
Ophthalmic
Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections.
Other
Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, malaise, moon face, weight gain.
Read the entire FDA prescribing information for Aristospan Injection 20 (Triamcinolone Hexacetonide Injectable Suspension)
&Copy; Aristospan Injection 20 Patient Information is supplied by Cerner Multum, Inc. and Aristospan Injection 20 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.